Ulrich Medical MILITARY

Target: ulrich GmbH & Co. KG, trading as ulrich medical.

Research date: 28 October 2026.

Research scope: Publicly documented military, defence, security-force, and military-adjacent relationships involving Israel, including occupied territories.

Direct Defence Contracting & Procurement

Corporate identity and ownership

Ulrich medical operates through ulrich GmbH & Co. KG, headquartered in Ulm, Germany, and describes its business as the development, manufacture, and distribution of medical equipment for radiology and spinal surgery.¹

Ulrich medical USA identifies Heinrich C. Ulrich as the company’s founder in 1912 and describes the enterprise as privately held and family-owned.²

The company’s 2026 corporate description identifies ulrich GmbH & Co. KG as the parent operating company of subsidiaries in France, Spain, and the United States.³

The manufacturer’s international locations page identifies direct operations in Germany, the United States, France, and Spain and reports distribution through specialist partners in other countries.⁴

The available corporate descriptions do not disclose a complete list of beneficial owners or identify every natural or legal person holding at least 10% of the company’s equity.^{1, 2}

Named controlling principals

Christoph Ulrich is identified as Managing Partner and the great-grandson of the founder; searches for his defence-industry directorships, Israeli military relationships, relevant investments, and military-directed donations yielded no public evidence identified.⁵

Friedrich von Rechteren became CEO and Chairman of the Management Board on 1 June 2025, succeeding Klaus Kiesel; searches for Israeli military procurement, defence-board roles, and settlement-related affiliations yielded no public evidence identified.⁶

Gordon Bittig joined the company in the fourth quarter of 2025 and became CFO and Managing Director at the beginning of 2026; searches for Israeli military, defence-industry, and settlement-related relationships yielded no public evidence identified.⁷

Klaus Kiesel served as CEO before the June 2025 succession; searches for Israeli military contracting and related defence affiliations yielded no public evidence identified.⁸

Heinrich C. Ulrich founded the company in 1912; searches concerning military-related acts involving Israel yielded no public evidence identified, and this historical relationship is [pre-2020].⁹

Heiner Ulrich transferred management responsibilities to Christoph Ulrich in 2009; searches for Israeli military and defence relationships yielded no public evidence identified, and the documented succession is [pre-2020].⁹

Sven Erdmann has held responsibility for technology and regulation as an authorised executive since 2018; searches for Israeli defence-industry affiliations yielded no public evidence identified, and the original appointment is [pre-2020].⁵

Steffen Kölsch has held responsibility for operations and quality management as an authorised executive since 2018; searches for Israeli military procurement relationships yielded no public evidence identified, and the original appointment is [pre-2020].⁵

Cornelia Schweizer has held senior responsibility for sales and marketing since 2021; searches for military-specific distribution, Israeli defence customers, and defence-industry affiliations yielded no public evidence identified.⁵

Named integrated entities

ulrich medical USA, Inc. was established in January 2006 and operates from the Dallas metropolitan area; searches for Israeli military contracts and defence procurement yielded no public evidence identified.¹⁰

ulrich medical France SAS was established in October 2017 as a wholly owned subsidiary and operates from the Toulouse area; searches for Israeli defence contracts and military customers yielded no public evidence identified.¹¹

ulrich medical España S.L. began operating in October 2024 with direct distribution of radiology equipment in Spain; searches for Israeli military or settlement-related contracts yielded no public evidence identified.¹²

The German headquarters remains responsible for significant medical-device development and manufacturing and coordinates the international subsidiaries; searches for military-specific production for Israel yielded no public evidence identified.¹³

Additional named subsidiary management

Eric Gibbs is identified as General Manager of ulrich medical USA, Inc.; searches for Israeli military business and defence-industry roles yielded no public evidence identified.¹⁴

Johnny Drake is identified as Commercial Vice President at the US subsidiary; searches for Israeli defence procurement and military-related business yielded no public evidence identified.¹⁴

Eric Lucas is identified as Global Vice President of Research and Development; searches for Israeli military research and weapons-system development yielded no public evidence identified.¹⁴

Lou Milos is identified as responsible for quality management in the US subsidiary; searches for Israeli military affiliations yielded no public evidence identified.¹⁴

Michael Gow is identified as Vice President of Business Development in the US subsidiary; searches for Israeli defence customers yielded no public evidence identified.¹⁴

Mohamed Taib is identified as General Manager of ulrich medical France SAS; searches for Israeli military contracts yielded no public evidence identified.¹¹

Christophe Martinez is identified as General Manager of ulrich medical España S.L.; searches for Israeli military procurement yielded no public evidence identified.¹²

Israeli defence contracting

No public evidence identified of a direct contract, tender award, framework agreement, or memorandum between ulrich GmbH & Co. KG or its identified subsidiaries and the Israeli Ministry of Defence, IDF, Israel Prison Service, Border Police, or another Israeli state security organisation in the materials examined.^{3, 4, 15}

No public evidence identified of an Ulrich-specific Israeli defence procurement registration, SIBAT listing, or announced military cooperation arrangement in the materials examined.^{3, 15}

The absence of a named military customer from the manufacturer’s public disclosures does not establish the absence of transactions through undisclosed distributors or procurement intermediaries.^{4, 16}

Dual-Use Products & Tactical Variants

Documented civilian product functions

Ulrich GmbH & Co. KG markets CT motion as a contrast-media injector for diagnostic computed tomography, including controlled administration of contrast agents and saline solution.¹⁷

The CT motion SPICY product comparison describes an expanded clinical injector configuration with increased pressure and flow capability; no military-specific designation is identified in that manufacturer comparison.¹⁸

The Max 3 system is marketed for contrast administration during MRI and contrast-enhanced mammography examinations, with manufacturer-described clinical workflow and patient-safety functions.¹⁹

The Max 2M and Max 3 product comparison identifies diagnostic imaging applications and technical differences between the devices, without specifying tactical or military use.²⁰

The uCentum system is described as a thoracolumbosacral spinal fixation and stabilization implant for adult patients, including open and minimally invasive surgical applications.²¹

The uBase system is described as an iliosacral fixation implant intended for clinical use in combination with uCentum.²²

The neon3 system is described as an occipitocervical spinal fixation system for adult patients and includes compatibility with surgical navigation equipment.²³

The ADD vertebral-body replacement device is described as a surgical implant for reconstruction following partial or complete corpectomy.²⁴

The ADDplus system combines vertebral-body replacement and fixation plates for specified cervical and thoracic spinal procedures.²⁵

Military-specific variants

No public evidence identified of purpose-built Israeli military variants, tactical modifications, military specifications, ballistic protection features, or weapons-related versions of these medical-device products in the manufacturer specifications examined.^{17, 18, 19, 21, 22, 23}

No public evidence identified of a named Israeli military end-user purchasing or operating a specified Ulrich medical-device model in the product and distribution documents examined.^{4, 16, 17}

Civilian-to-military distinction

The manufacturer documents medical diagnostic and surgical applications, but the public product descriptions do not identify the ultimate purchasers of every individual device or implant.^{17, 19, 21}

The clinical utility of a medical device does not itself establish that the manufacturer supplied it to a military purchaser; no named Israeli military customer was established in the examined product disclosures.^{17, 19, 21}

Export documentation

No public evidence identified of an Israeli military end-user certificate, military-specific export licence, or export-control determination for the products examined.^{4, 26}

Heavy Machinery, Construction & Infrastructure

Equipment categories

The manufacturer’s published portfolio focuses on radiology and spinal-surgery devices rather than construction machinery, earthmoving equipment, demolition systems, or military engineering vehicles.^{3, 15}

No public evidence identified of Ulrich-branded heavy equipment used for Israeli settlement construction, military-base expansion, checkpoint construction, the separation barrier, or demolitions in occupied territories in the examined materials.^{13, 15}

Direct and indirect supply

The company identifies a network of international specialist distributors, but the reviewed public service information does not establish military end-users or the final destination of every product distributed through that network.^{4, 26}

No public evidence identified of direct or indirect supply of Ulrich construction machinery to Israeli military installations or settlement infrastructure.^{13, 15}

Infrastructure contracts

No public evidence identified of contracts involving ulrich GmbH & Co. KG or the identified subsidiaries for checkpoint construction, detention-facility expansion, settlement infrastructure, military-base engineering, or separation-barrier works.^{3, 13, 15}

Supply Chain Integration with Defence Primes

Documented commercial relationships

On 28 November 2022, ulrich GmbH & Co. KG announced an agreement with GE Healthcare for distribution of GE-branded CT motion injectors manufactured by Ulrich in the United States; the announcement identifies diagnostic imaging as the commercial application.²⁷

The acting entity was ulrich GmbH & Co. KG, the commercial counterparty was GE Healthcare, and the communication channel was the manufacturer’s own website; the earliest dated observation examined was 28 November 2022, the company was to remain the legal manufacturer, and the agreement’s current contractual status and final termination date are not established by the cited announcement.²⁷

On 21 November 2023, ulrich GmbH & Co. KG announced a cooperation agreement with Bracco Imaging S.p.A. to distribute Ulrich-manufactured MRI injectors under the Bracco brand in the United States.²⁸

The acting entity was ulrich GmbH & Co. KG, the counterparty was Bracco Imaging S.p.A., and the communication channel was the manufacturer’s website; the earliest dated observation examined was 21 November 2023, the announcement described a long-term commercial partnership, and its present contractual status and termination date remain unverified.²⁸

The GE Healthcare and Bracco Imaging announcements concern medical diagnostic equipment in the United States and do not identify an Israeli defence-sector customer, military programme, weapons platform, or military-specific product variant.^{27, 28}

Historical distributor relationship

On 24 September 2024, ulrich medical announced that EuroAutomation, its longstanding Spanish distributor, would transfer the relevant contrast-media injector business to the newly established Spanish subsidiary.²⁹

The acting entities were ulrich GmbH & Co. KG, EuroAutomation, and ulrich medical España; the beneficiary was the Spanish civilian medical-device sales operation, the communication appeared on the manufacturer’s website, and the announcement documented an intended business transfer without independently establishing the exact date on which every historical distributor obligation ended.²⁹

No Israeli military or settlement-related end-user is identified in the EuroAutomation announcement.²⁹

Defence-prime relationships

No public evidence identified of direct component sales, manufacturing services, licensed production, or joint development between Ulrich and Elbit Systems, Israel Aerospace Industries, Rafael Advanced Defense Systems, or Israel Military Industries in the company disclosures examined.^{3, 15, 27, 28}

No public evidence identified of Ulrich-manufactured optical guidance, radar, propulsion, targeting, fire-control, armour, or communications subsystems supplied to Israeli defence manufacturers.^{17, 18, 19, 21, 22}

Third-party surgical technology

The uCentum manufacturer’s specification identifies compatibility with Brainlab and Medtronic surgical navigation systems, while the neon3 specification also describes Brainlab-assisted surgical planning and insertion.^{21, 23}

These disclosures establish a medical-technology compatibility relationship and do not identify a military targeting application or a contract with an Israeli defence prime.^{21, 23}

The announcement-date discrepancy reflects two different dates in Ulrich Medical’s own public records. Its online announcement and news archive give 21 November 2023, confirming the existing audit statement that the Bracco Imaging MRI-injector cooperation was announced on that date and the subsequent statement identifying 21 November as the earliest dated observation. However, Ulrich Medical’s downloadable English press-release PDF is dated 24 November 2023. These dates should be distinguished as the website announcement date and the date printed on the downloadable release. Bracco Imaging independently announced the same agreement on 22 November 2023, confirming that the partnership was publicly announced before 24 November. The existing audit’s 21 November date is therefore supported as Ulrich Medical’s website announcement date, although it does not match the date printed on the manufacturer’s PDF.^{30, 31}

Logistical Sustainment & Base Services

Medical-device support

Ulrich’s published radiology service arrangements describe application support, technical assistance, maintenance guidance, training, and support through certified distributors.²⁶

The company headquarters separately identifies technical support, application training, and surgical assistance among its medical-device services.¹³

These disclosures identify ordinary medical-device support activities without naming an Israeli military installation or security-force customer.^{13, 26}

Military-base and detention-facility services

No public evidence identified of Ulrich contracts for catering, fuel, transport, waste management, facilities maintenance, telecommunications, or logistical sustainment at IDF bases, Israeli detention facilities, or security installations.^{3, 13, 26}

Geographic specificity

The identified direct subsidiaries operate in Germany, the United States, France, and Spain; the cited location disclosures do not establish an Ulrich-owned site in the West Bank, East Jerusalem, Golan Heights, or another occupied territory.^{4, 10, 11, 12}

No public evidence identified of Ulrich service activity at a named Israeli military site in the West Bank, East Jerusalem, Golan Heights, or the Negev.^{4, 13, 26}

Shipping and military cargo

No public evidence identified of an Ulrich contract for handling military cargo, forwarding arms shipments, operating military port services, or sustaining Israeli military supply routes.^{3, 4, 26}

Munitions, Weapons Systems & Strategic Platforms

Lethal systems

The manufacturer’s disclosed product families consist of medical diagnostic equipment, surgical implants, and associated medical-device accessories and services.^{3, 15}

No public evidence identified of Ulrich manufacturing or supplying firearms, artillery, armoured vehicles, military drones, naval weapons, or other lethal systems to Israeli forces.^{3, 15, 17}

Munitions

No public evidence identified of Ulrich supplying ammunition, explosive ordnance, chemical propellants, warhead components, or military munitions precursors to Israel in the examined disclosures.^{3, 15}

Strategic defence platforms

No public evidence identified of participation by Ulrich in Iron Dome, David’s Sling, Arrow, Israeli military aviation platforms, main battle tanks, warships, or ballistic-missile systems.^{3, 15}

Critical military subsystems

No public evidence identified of Israeli military use of Ulrich-developed targeting software, weapons-integration software, precision-guidance systems, fire-control electronics, radar components, or military propulsion systems.^{17, 19, 21, 23}

The documented software functions associated with CT motion concern clinical imaging workflows, contrast-media administration, examination synchronisation, and diagnostic documentation.^{17, 18}

Export Licensing, Regulatory & Legal History

Medical-device regulation

The manufacturer reports that CT motion and Max injectors and selected spinal implant systems achieved certification under the European Medical Device Regulation in January 2024.⁹

The company’s historical timeline also records FDA approval for CT motion in 2019, a [pre-2020] medical-device regulatory event.⁹

The November 2023 Bracco cooperation announcement identifies a US FDA 510(k) submission relating to an MRI injector, providing evidence of medical-device regulatory activity rather than an Israeli defence export authorisation.²⁸

Export licences

No public evidence identified of a licence granted, denied, suspended, or revoked specifically for Ulrich military or security-related exports to Israel in the reviewed company documents.^{4, 27, 28}

Sanctions and embargo compliance

The company’s compliance page describes a corporate commitment to applicable laws and regulations and the availability of a whistleblower reporting mechanism.³²

No public evidence identified in the examined material of a sanctions-enforcement action, arms-embargo violation, or export-control penalty involving Ulrich military supply to Israel.^{15, 32}

Legal proceedings

No public evidence identified in the materials examined of a judicial review, civil claim, OECD National Contact Point complaint, or other legal proceeding alleging that Ulrich supplied military equipment to Israeli armed or security forces.^{15, 32}

Constructive-notice chronology

The 24 September 2024 Spanish expansion announcement and the January 2026 management announcement document corporate activities after 19 July 2024 and November 2024, but neither identifies continued Israeli military supply.^{7, 29}

The 2025 leadership transition and the 2026 corporate updates do not establish a military-related act continuing after either of those dates.^{6, 7, 15}

No public evidence identified of an Ulrich-specific shareholder resolution, employee letter, sanctions notice, or civil-society demand concerning Israeli military supply followed by documented continuation of that supply.^{15, 32}

Civil Society Scrutiny & Documented Investigations

Publicly documented company activities

Ulrich’s 2025 financial update reported group revenue of €163 million for 2024 and identified contrast-media injectors as an important commercial growth driver.³³

Its 2026 public news archive describes the group as a medical-technology manufacturer operating in radiology and spinal surgery.¹⁵

The company’s public statements describe international medical-device development, manufacturing, and distribution, including commercial partnerships in civilian diagnostic imaging.^{3, 27, 28}

Civil-society investigations

No publicly retrievable company-specific finding concerning Israeli military contracting or military-adjacent supply was established through the searches directed at Who Profits, AFSC Investigate, OHCHR, UN Special Rapporteur materials, Amnesty International, Human Rights Watch, Al-Haq, SOMO, BankTrack, B’Tselem, or associated civil-society investigations; the accessible manufacturer disclosures cited here provide corporate context and do not independently verify exclusion from those databases.^{3, 15}

No public evidence identified of a named academic investigation establishing an Ulrich-manufactured component in an Israeli weapons programme in the reviewed corporate and product records.^{15, 17, 21}

Boycott and divestment

No public evidence identified of an organised Ulrich-specific boycott, institutional divestment decision, or pension-fund exclusion expressly based on supplying Israeli military equipment in the materials examined.^{15, 32}

No public evidence identified of a corporate response to a named Israeli-military-related boycott campaign, termination of an Israeli military contract following civil-society pressure, or a military-specific end-use monitoring commitment.^{15, 32}

Named-entity and ownership limitations

The current company disclosures identify Christoph Ulrich as managing partner and establish private family ownership, but the reviewed documents do not provide a complete, independently verified shareholder register or disclose every holder of 10% or more equity.^{2, 5}

The named group companies are ulrich medical USA, Inc., ulrich medical France SAS, and ulrich medical España S.L., and their public descriptions establish civilian medical-device sales, development, or support activities.^{10, 11, 12}

No verified military-channel act was established for the named founders, current controlling principals, former CEO, subsidiary executives, or identified commercial partners in the accessible evidence examined.^{5, 6, 7, 10, 11, 12, 27, 28}

Act-record boundaries

The verified 2022 GE Healthcare distribution agreement was a corporate communication by ulrich GmbH & Co. KG concerning US medical imaging; the public announcement identifies the acting party, beneficiary, product, territory, and announcement date, but does not establish the exact publication end date, communication audience size, or contractual cessation date.²⁷

The verified 2023 Bracco Imaging agreement was a corporate communication by ulrich GmbH & Co. KG concerning US medical imaging; the public announcement identifies the acting party, beneficiary, product, territory, and announcement date, but does not establish the exact publication end date, communication audience size, or contractual cessation date.²⁸

The verified September 2024 EuroAutomation announcement concerns the transfer of a Spanish medical-device distribution business; the public record identifies the parties, intended transaction, and announcement date, but does not establish any Israeli military beneficiary.²⁹

The manufacturer continues to publish information about these relationships and its corporate history through publicly accessible pages as of the October 2026 research date, although the continuing availability of a webpage does not independently establish the continuing performance of the underlying commercial contract.^{9, 15, 27, 28}

No public evidence identified of a specific military-related act for which an Israeli security-force recipient, delivery channel, contract period, and continuing or terminated status could be independently recorded.^{3, 15, 27, 28}